| 1 |
Cell wall glucomannan in Arabidopsis is synthesised by CSLA glycosyltransferases, and influences the progression of embryogenesis
Florence Goubet, Christopher J. Barton, Jennifer C. Mortimer et al. · The Plant Journal
Open access |
13 Jul 2009 |
234 |
| 2 |
Evaluation of Epidemiological Cut-Off Values Indicates that Biocide Resistant Subpopulations Are Uncommon in Natural Isolates of Clinically-Relevant Microorganisms
Ian Morrissey, Marco Rinaldo Oggioni, Daniel R. Knight et al. · PLoS ONE
Open access |
23 Jan 2014 |
199 |
| 3 |
Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis
Richard G. Kay, Chris Barton, Lucy Ratcliffe et al. · Rapid Communications in Mass Spectrometry
|
22 Sep 2008 |
169 |
| 4 |
On the Colonic Bacterial Metabolism of Azo-Bonded Prodrugsof 5-Aminosalicylic Acid
Tiago Sousa, Vipul Yadav, Vanessa Zann et al. · Journal of Pharmaceutical Sciences
|
4 Aug 2014 |
141 |
| 5 |
Tritium: a coming of age for drug discovery and development ADME studies
W. J. S. Lockley, Andrew McEwen, Roger Cooke · Journal of Labelled Compounds and Radiopharmaceuticals
|
15 Jun 2012 |
136 |
| 6 |
Metabolic Disposition of Osimertinib in Rats, Dogs, and Humans: Insights into a Drug Designed to Bind Covalently to a Cysteine Residue of Epidermal Growth Factor Receptor
Paul Alfred Dickinson, Mireille Cantarini, J. Collier et al. · Drug Metabolism and Disposition
|
26 May 2016 |
134 |
| 7 |
The Effect of Hematocrit on Bioanalysis of DBS: Results from The EBF DBS-Microsampling Consortium
Ronald de Vries, Matthew D. Barfield, Nico van de Merbel et al. · Bioanalysis
|
5 Jul 2013 |
134 |
| 8 |
Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody
Mary M. Reilly, R. Matthew Miller, MA Thomson et al. · Clinical Pharmacology & Therapeutics
Open access |
23 Jul 2013 |
122 |
| 9 |
Evaluation of Reduced Susceptibility to Quaternary Ammonium Compounds and Bisbiguanides in Clinical Isolates and Laboratory-Generated Mutants of Staphylococcus aureus
Leonardo Furi, Maria Laura Ciusa, Daniel R. Knight et al. · Antimicrobial Agents and Chemotherapy
Open access |
14 May 2013 |
118 |
| 10 |
Update of The EBF Recommendation for The Use of DBS in Regulated Bioanalysis Integrating The Conclusions from The EBF DBS-Microsampling Consortium
Philip Timmerman, Steve White, Zoe Cobb et al. · Bioanalysis
|
5 Jul 2013 |
111 |
| 11 |
Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: The VetPath study
Anno de Jong, Valerie M. Thomas, Shabbir Simjee et al. · Veterinary Microbiology
|
21 Apr 2014 |
109 |
| 12 |
MRMaid, the Web-based Tool for Designing Multiple Reaction Monitoring (MRM) Transitions
Jennifer A. Mead, Luca Bianco, Vanessa Ottone et al. · Molecular & Cellular Proteomics
Open access |
16 Nov 2008 |
105 |
| 13 |
A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus
Maria Laura Ciusa, Leonardo Furi, Daniel R. Knight et al. · International Journal of Antimicrobial Agents
Open access |
11 Jul 2012 |
103 |
| 14 |
Investigation of the Potential for Mutational Resistance to XF-73, Retapamulin, Mupirocin, Fusidic Acid, Daptomycin, and Vancomycin in Methicillin-Resistant Staphylococcus aureus Isolates during a 55-Passage Study
David J. Farrell, M J Robbins, W. Rhys‐Williams et al. · Antimicrobial Agents and Chemotherapy
Open access |
13 Dec 2010 |
93 |
| 15 |
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
Johannes Levin, Nand Sing, Sue Melbourne et al. · EBioMedicine
Open access |
29 Apr 2022 |
92 |
| 16 |
Presence and metabolism of endogenous androgenic–anabolic steroid hormones in meat-producing animals: a review
James P. Scarth, Christine J. Akre, Leendert van Ginkel et al. · Food Additives & Contaminants Part A
|
May 2009 |
89 |
| 17 |
Recommendations On: Internal Standard Criteria, Stability, Incurred Sample Reanalysis and Recent 483s by the Global CRO Council for Bioanalysis
Steve Lowes et al. · Bioanalysis
|
Jun 2011 |
89 |
| 18 |
Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery
Andrew L. Lewis, Nicholas McEntee, Justin Holland et al. · Drug Delivery and Translational Research
|
22 May 2021 |
82 |
| 19 |
Chain length affects pancreatic lipase activity and the extent and pH–time profile of triglyceride lipolysis
Paloma Benito-Gallo, Alessandro Franceschetto, Jonathan C.M. Wong et al. · European Journal of Pharmaceutics and Biopharmaceutics
Open access |
2 May 2015 |
80 |
| 20 |
The MUT056399 Inhibitor of FabI Is a New Antistaphylococcal Compound
Sonia Escaich, Laure Prouvensier, Marc Saccomani et al. · Antimicrobial Agents and Chemotherapy
Open access |
9 Aug 2011 |
79 |
| 21 |
Patient-ventilator asynchrony in adult critically ill patients
Andrea Bruni, Eugenio Garofalo, Corrado Pelaia et al. · Minerva Anestesiologica
|
May 2019 |
78 |
| 22 |
2013 White Paper on Recent Issues in Bioanalysis: ‘ Hybrid ’ – The Best of LBA and LCMS
Lauren F. Stevenson et al. · Bioanalysis
|
10 Oct 2013 |
75 |
| 23 |
Generic Approach to Validation of Small-Molecule LC–MS/MS Biomarker Assays
Richard C. Houghton, Catarina Horro Pita, Ian Macmillan Ward et al. · Bioanalysis
|
Nov 2009 |
72 |
| 24 |
Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats
Paulo V M Steagall, Ludovic Pelligand, Tatiana Giordano et al. · Veterinary Anaesthesia and Analgesia
Open access |
24 Sep 2012 |
71 |
| 25 |
High‐throughput ultra‐high‐performance liquid chromatography/tandem mass spectrometry quantitation of insulin‐like growth factor‐I and leucine‐rich α‐2‐glycoprotein in serum as biomarkers of recombinant human growth hormone administration
Richard G. Kay, Chris Barton, Cristiana P. Velloso et al. · Rapid Communications in Mass Spectrometry
|
29 Aug 2009 |
68 |
| 26 |
Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacological Effect of Orally Administered CORT125134: An Adaptive, Double‐Blind, Randomized, Placebo‐Controlled Phase 1 Clinical Study
Hazel Hunt, Kirsteen M. Donaldson, Mark Strem et al. · Clinical Pharmacology in Drug Development
Open access |
2 Oct 2017 |
65 |
| 27 |
In-Depth Study of Homogeneity in DBS Using Two Different Techniques: Results from The EBF DBS-Microsampling Consortium
Zoe Cobb, Ronald de Vries, Neil Spooner et al. · Bioanalysis
|
5 Jul 2013 |
64 |
| 28 |
Scleroderma with an update about clinico-pathological correlation
Franco Rongioletti, Caterina Ferreli, Laura Atzori et al. · Italian Journal of Dermatology and Venereology
|
Mar 2018 |
63 |
| 29 |
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide
Maria Serrano Gregori, Mark Taylor, Elisa Salvati et al. · Nanomedicine Nanotechnology Biology and Medicine
Open access |
19 Oct 2016 |
62 |
| 30 |
Recommendations on Biomarker Bioanalytical Method Validation By Gcc
Richard Hougton et al. · Bioanalysis
|
Oct 2012 |
62 |
| 31 |
Assessment of Tacrolimus Absorption From the Human Intestinal Tract: Open-Label, Randomized, 4-Way Crossover Study
Daisuke Tsunashima, Akio Kawamura, Manabu Murakami et al. · Clinical Therapeutics
|
27 Mar 2014 |
61 |
| 32 |
Drug metabolism in the horse: a review
James P. Scarth, Phil Teale, Tiia Kuuranne · Drug Testing and Analysis
|
22 Oct 2010 |
61 |
| 33 |
European Bioanalysis Forum Recommendation on Method Establishment And Bioanalysis of Biomarkers in Support of Drug Development
Philip Timmerman, Christian Herling, Daniela Stoellner et al. · Bioanalysis
|
Aug 2012 |
59 |
| 34 |
Netupitant PET imaging and ADME studies in humans
Tulla Spinelli, Selma Calcagnile, Claudio Giuliano et al. · The Journal of Clinical Pharmacology
Open access |
12 Oct 2013 |
59 |
| 35 |
Somatic mutation and selection at population scale
Andrew R. J. Lawson et al. · Nature
Open access |
8 Oct 2025 |
57 |
| 36 |
bro β-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults
Mushtaq Ahmad Khan, John Blackman Northwood, Foster Levy et al. · Journal of Antimicrobial Chemotherapy
Open access |
4 Nov 2009 |
57 |
| 37 |
Analysis of single-molecule mechanical recordings: application to acto-myosin interactions
Alex E. Knight, Claudia Veigel, Charles Chambers et al. · Progress in Biophysics and Molecular Biology
Open access |
2001 |
57 |
| 38 |
Naloxone as part of a prolonged release oxycodone/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers
Kevin J. Smith, Michael Hopp, Gill Mundin et al. · Expert Opinion on Investigational Drugs
|
14 Mar 2011 |
56 |
| 39 |
Metabolism and disposition of the dipeptidyl peptidase IV inhibitor teneligliptin in humans
Yoshinobu Nakamaru, Yoshiharu Hayashi, Ruriko Ikegawa et al. · Xenobiotica
|
15 Jul 2013 |
56 |
| 40 |
Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia
Ian Morrissey, Yigong Ge, Regina Janes · International Journal of Antimicrobial Agents
|
9 Feb 2009 |
55 |
| 41 |
Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes
Rosy Reynolds, Russell Hope, Laura Williams et al. · Journal of Antimicrobial Chemotherapy
|
26 Sep 2008 |
54 |
| 42 |
Determination of Avibactam and Ceftazidime in Human Plasma Samples by LC–MS
Henrik Sillén, Richard James Mitchell, Rebecca Sleigh et al. · Bioanalysis
|
Jul 2015 |
53 |
| 43 |
The Use of Machine Learning Methodologies to Analyse Antibiotic and Biocide Susceptibility in Staphylococcus aureus
Joana Rosado Coelho, João André Carriço, Daniel R. Knight et al. · PLoS ONE
Open access |
19 Feb 2013 |
53 |
| 44 |
Assessment of the Mass Balance Recovery and Metabolite Profile of Avibactam in Humans and In Vitro Drug-Drug Interaction Potential
Karthick Vishwanathan, Stuart J. Mair, Anshul Gupta et al. · Drug Metabolism and Disposition
|
11 Mar 2014 |
52 |
| 45 |
Reduction of misleading (“false”) positive results in mammalian cell genotoxicity assays. III: Sensitivity of human cell types to known genotoxic agents
Paul Fowler, Robert Smith, Katie Smith et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
|
17 Mar 2014 |
52 |
| 46 |
Quantitative Whole-Body Autoradiography: Past, Present and Future
Andrew McEwen, Claire Henson · Bioanalysis
|
Mar 2015 |
52 |
| 47 |
Comparative activity of carbapenem testing: the COMPACT study
Patrice Nordmann et al. · Journal of Antimicrobial Chemotherapy
Open access |
8 Mar 2011 |
51 |
| 48 |
Evaluation of regional gastrointestinal absorption of edoxaban using the enterion capsule
Dolly A. Parasrampuria, Taro Kanamaru, Alyson L. Connor et al. · The Journal of Clinical Pharmacology
Open access |
12 May 2015 |
51 |
| 49 |
In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets
Anette Loeffler, STEPHEN J. BAINES, Mark Alexander Toleman et al. · Journal of Antimicrobial Chemotherapy
Open access |
10 Sep 2008 |
47 |
| 50 |
Recommendations on The Interpretation of The New European Medicines Agency Guideline on Bioanalytical Method Validation By Global Cro Council For Bioanalysis (Gcc)
Mark Boterman et al. · Bioanalysis
|
Mar 2012 |
45 |